These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
641 related articles for article (PubMed ID: 34161316)
1. Global seroprevalence of SARS-CoV-2 antibodies: A systematic review and meta-analysis. Bobrovitz N; Arora RK; Cao C; Boucher E; Liu M; Donnici C; Yanes-Lane M; Whelan M; Perlman-Arrow S; Chen J; Rahim H; Ilincic N; Segal M; Duarte N; Van Wyk J; Yan T; Atmaja A; Rocco S; Joseph A; Penny L; Clifton DA; Williamson T; Yansouni CP; Evans TG; Chevrier J; Papenburg J; Cheng MP PLoS One; 2021; 16(6):e0252617. PubMed ID: 34161316 [TBL] [Abstract][Full Text] [Related]
2. Global SARS-CoV-2 seroprevalence from January 2020 to April 2022: A systematic review and meta-analysis of standardized population-based studies. Bergeri I; Whelan MG; Ware H; Subissi L; Nardone A; Lewis HC; Li Z; Ma X; Valenciano M; Cheng B; Al Ariqi L; Rashidian A; Okeibunor J; Azim T; Wijesinghe P; Le LV; Vaughan A; Pebody R; Vicari A; Yan T; Yanes-Lane M; Cao C; Clifton DA; Cheng MP; Papenburg J; Buckeridge D; Bobrovitz N; Arora RK; Van Kerkhove MD; PLoS Med; 2022 Nov; 19(11):e1004107. PubMed ID: 36355774 [TBL] [Abstract][Full Text] [Related]
3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
4. Seroprevalence of SARS-CoV-2 antibodies and associated factors in healthcare workers: a systematic review and meta-analysis. Galanis P; Vraka I; Fragkou D; Bilali A; Kaitelidou D J Hosp Infect; 2021 Feb; 108():120-134. PubMed ID: 33212126 [TBL] [Abstract][Full Text] [Related]
5. Estimated US Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence Based on Blood Donations, July 2020-May 2021. Jones JM; Stone M; Sulaeman H; Fink RV; Dave H; Levy ME; Di Germanio C; Green V; Notari E; Saa P; Biggerstaff BJ; Strauss D; Kessler D; Vassallo R; Reik R; Rossmann S; Destree M; Nguyen KA; Sayers M; Lough C; Bougie DW; Ritter M; Latoni G; Weales B; Sime S; Gorlin J; Brown NE; Gould CV; Berney K; Benoit TJ; Miller MJ; Freeman D; Kartik D; Fry AM; Azziz-Baumgartner E; Hall AJ; MacNeil A; Gundlapalli AV; Basavaraju SV; Gerber SI; Patton ME; Custer B; Williamson P; Simmons G; Thornburg NJ; Kleinman S; Stramer SL; Opsomer J; Busch MP JAMA; 2021 Oct; 326(14):1400-1409. PubMed ID: 34473201 [TBL] [Abstract][Full Text] [Related]
6. Estimating global, regional, and national daily and cumulative infections with SARS-CoV-2 through Nov 14, 2021: a statistical analysis. COVID-19 Cumulative Infection Collaborators Lancet; 2022 Jun; 399(10344):2351-2380. PubMed ID: 35405084 [TBL] [Abstract][Full Text] [Related]
7. Update on SARS-CoV-2 seroprevalence: regional and worldwide. Rostami A; Sepidarkish M; Fazlzadeh A; Mokdad AH; Sattarnezhad A; Esfandyari S; Riahi SM; Mollalo A; Dooki ME; Bayani M; Nazemipour M; Mansournia MA; Hotez PJ; Gasser RB Clin Microbiol Infect; 2021 Dec; 27(12):1762-1771. PubMed ID: 34582980 [TBL] [Abstract][Full Text] [Related]
9. Seroprevalence of SARS-CoV-2 IgG antibodies among health care workers prior to vaccine administration in Europe, the USA and East Asia: A systematic review and meta-analysis. Hossain A; Nasrullah SM; Tasnim Z; Hasan MK; Hasan MM EClinicalMedicine; 2021 Mar; 33():100770. PubMed ID: 33718853 [TBL] [Abstract][Full Text] [Related]
10. Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study. Stringhini S; Wisniak A; Piumatti G; Azman AS; Lauer SA; Baysson H; De Ridder D; Petrovic D; Schrempft S; Marcus K; Yerly S; Arm Vernez I; Keiser O; Hurst S; Posfay-Barbe KM; Trono D; Pittet D; Gétaz L; Chappuis F; Eckerle I; Vuilleumier N; Meyer B; Flahault A; Kaiser L; Guessous I Lancet; 2020 Aug; 396(10247):313-319. PubMed ID: 32534626 [TBL] [Abstract][Full Text] [Related]
11. SARS-CoV-2 infection in Africa: a systematic review and meta-analysis of standardised seroprevalence studies, from January 2020 to December 2021. Lewis HC; Ware H; Whelan M; Subissi L; Li Z; Ma X; Nardone A; Valenciano M; Cheng B; Noel K; Cao C; Yanes-Lane M; Herring BL; Talisuna A; Ngoy N; Balde T; Clifton D; Van Kerkhove MD; Buckeridge D; Bobrovitz N; Okeibunor J; Arora RK; Bergeri I; BMJ Glob Health; 2022 Aug; 7(8):. PubMed ID: 35998978 [TBL] [Abstract][Full Text] [Related]
12. Seroprevalence of severe acute respiratory syndrome coronavirus 2 in Slovenia: results of two rounds of a nationwide population study on a probability-based sample, challenges and lessons learned. Poljak M; Oštrbenk Valenčak A; Štrumbelj E; Maver Vodičar P; Vehovar V; Resman Rus K; Korva M; Knap N; Seme K; Petrovec M; Zupan B; Demšar J; Kurdija S; Avšič Županc T Clin Microbiol Infect; 2021 Jul; 27(7):1039.e1-1039.e7. PubMed ID: 33838303 [TBL] [Abstract][Full Text] [Related]
13. Prevalence of SARS-CoV-2 antibodies among nurses: A systematic review and meta-analysis. He S; Hecimovic A; Matijasevic V; Mai HT; Heslop L; Foster J; Alexander KE; Pal N; Alexandrou E; Davidson PM; Frost SA J Clin Nurs; 2022 Jun; 31(11-12):1557-1569. PubMed ID: 34570947 [TBL] [Abstract][Full Text] [Related]
14. Seroprevalence of SARS-CoV-2 Infection in Portugal in May-July 2020: Results of the First National Serological Survey (ISNCOVID-19). Kislaya I; Gonçalves P; Barreto M; Sousa R; Garcia AC; Matos R; Guiomar R; Rodrigues AP; Acta Med Port; 2021 Feb; 34(2):87-94. PubMed ID: 33641702 [TBL] [Abstract][Full Text] [Related]
15. Estimated SARS-CoV-2 Seroprevalence in US Patients Receiving Dialysis 1 Year After the Beginning of the COVID-19 Pandemic. Anand S; Montez-Rath M; Han J; Cadden L; Hunsader P; Kerschmann R; Beyer P; Boyd SD; Garcia P; Dittrich M; Block GA; Parsonnet J; Chertow GM JAMA Netw Open; 2021 Jul; 4(7):e2116572. PubMed ID: 34251441 [TBL] [Abstract][Full Text] [Related]
16. SARS-CoV-2 Antibody Testing in Health Care Workers: A Comparison of the Clinical Performance of Three Commercially Available Antibody Assays. Allen N; Brady M; Carrion Martin AI; Domegan L; Walsh C; Houlihan E; Kerr C; Doherty L; King J; Doheny M; Griffin D; Molloy M; Dunne J; Crowley V; Holmes P; Keogh E; Naughton S; Kelly M; O'Rourke F; Lynagh Y; Crowley B; de Gascun C; Holder P; Bergin C; Fleming C; Ni Riain U; Conlon N; Microbiol Spectr; 2021 Oct; 9(2):e0039121. PubMed ID: 34585976 [TBL] [Abstract][Full Text] [Related]